Please try another search
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology. The company offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. It has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. The company was incorporated in 2019 and is based in Cambridge, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Anastasia Khvovora | 54 | 2022 | Member of Scientific Advisory Board |
Agnieszka Czechowicz | - | 2022 | Member of Scientific Advisory Board |
David R. Liu | - | 2022 | Co-Founder & Chair of Scientific Advisory Board |
Wendy K. Chung | 54 | 2021 | Independent Director |
Robert Taylor Nelsen | 61 | 2020 | Independent Director |
Yvonne Chen | - | 2022 | Member of Scientific Advisory Board |
Keith Michael Gottesdiener | 69 | 2020 | President, CEO, Secretary & Director |
Eric N. Olson | - | - | Member of Scientific Advisory Board |
Kaye I. Foster-Cheek | 63 | 2021 | Independent Director |
Guangping Gao | - | 2022 | Member of Scientific Advisory Board |
David P. Schenkein | 66 | 2019 | Independent Director |
James Haber | - | 2022 | Member of Scientific Advisory Board |
Samuel H. Sternberg | - | 2022 | Member of Scientific Advisory Board |
Shengdar Q. Tsai | - | 2022 | Member of Scientific Advisory Board |
Jay Shendure | - | 2022 | Member of Scientific Advisory Board |
Michael A. Kelly | 66 | 2021 | Independent Director |
Muthiah Manoharan | 70 | 2022 | Member of Scientific Advisory Board |
Ben Kleinstiver | - | 2022 | Member of Scientific Advisory Board |
Thomas J. Cahill | 36 | 2021 | Independent Director |
Jeffrey D. Marrazzo | 44 | 2023 | Director |
Gerald Schwank | - | 2023 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review